These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

865 related items for PubMed ID: 19696005

  • 1. [Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status].
    Bensouda Y, André F, Boulet T, Al-Ghuzlan A, Conforti R, Troalen F, Bourgier C, Errihani H, Spielmann M, Delaloge S.
    Bull Cancer; 2009 Oct; 96(10):923-8. PubMed ID: 19696005
    [Abstract] [Full Text] [Related]

  • 2. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J, Kruszewski WJ, Sliwińska M, Kruszewska E, Hajdukiewicz W, Sliwiński W, Rolka-Stempniewicz G, Góralczyk M, Leśniewski-Kmak K.
    Przegl Lek; 2001 Oct; 58(6):498-503. PubMed ID: 11816740
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of serum HER2 and CA 15-3 at the time of diagnosis of metastatic breast cancer.
    Fehm T, Jäger W, Krämer S, Sohn C, Solomayer E, Wallwiener D, Gebauer G.
    Anticancer Res; 2004 Oct; 24(3b):1987-92. PubMed ID: 15274389
    [Abstract] [Full Text] [Related]

  • 4. Expression of the calcium receptor in human breast cancer--a potential new marker predicting the risk of bone metastases.
    Mihai R, Stevens J, McKinney C, Ibrahim NB.
    Eur J Surg Oncol; 2006 Jun; 32(5):511-5. PubMed ID: 16564154
    [Abstract] [Full Text] [Related]

  • 5. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.
    St Romain P, Madan R, Tawfik OW, Damjanov I, Fan F.
    Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040
    [Abstract] [Full Text] [Related]

  • 6. Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status.
    Park YH, Lee S, Cho EY, Choi YL, Lee JE, Nam SJ, Yang JH, Ahn JS, Im YH.
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):507-16. PubMed ID: 19956951
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up.
    Samy N, Ragab HM, El Maksoud NA, Shaalan M.
    Cancer Biomark; 2010 Aug; 6(2):63-72. PubMed ID: 20571232
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. HER2 status in patients with breast carcinoma is not modified selectively by preoperative chemotherapy and is stable during the metastatic process.
    Vincent-Salomon A, Jouve M, Genin P, Fréneaux P, Sigal-Zafrani B, Caly M, Beuzeboc P, Pouillart P, Sastre-Garau X.
    Cancer; 2002 Apr 15; 94(8):2169-73. PubMed ID: 12001113
    [Abstract] [Full Text] [Related]

  • 12. Variations in tumor marker levels in metastatic breast cancer patients according to tumor subtypes.
    Kos T, Aksoy S, Sendur MA, Arik Z, Civelek B, Kandemir N, Ozdemir NY, Zengin N, Altundag K.
    J BUON; 2013 Apr 15; 18(3):608-13. PubMed ID: 24065471
    [Abstract] [Full Text] [Related]

  • 13. CA15-3: a reliable indicator of metastatic bone disease in breast cancer patients.
    O'Brien DP, Horgan PG, Gough DB, Skehill R, Grimes H, Given HF.
    Ann R Coll Surg Engl; 1992 Jan 15; 74(1):9-11; discussion 12. PubMed ID: 1736805
    [Abstract] [Full Text] [Related]

  • 14. Relationship between tumor markers CEA and CA 15-3, TNM staging, estrogen receptor rate and MIB-1 index in patients with pT1-2 breast cancer.
    Lumachi F, Basso SM, Brandes AA, Pagano D, Ermani M.
    Anticancer Res; 2004 Jan 15; 24(5B):3221-4. PubMed ID: 15510614
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Androgen receptors: a marker to increase sensitivity for identifying breast cancer in skin metastasis of unknown primary site.
    Bayer-Garner IB, Smoller B.
    Mod Pathol; 2000 Feb 15; 13(2):119-22. PubMed ID: 10697267
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Changes of serum HER2 status during clinical course of metastatic breast cancer patients.
    Fehm T, Jäger W, Kraemer S, Sohn C, Solomayer-Meyberg G, Solomayer EF, Kurek R, Wallwiener D, Gebauer G.
    Anticancer Res; 2004 Feb 15; 24(6):4205-10. PubMed ID: 15739264
    [Abstract] [Full Text] [Related]

  • 20. Primary and secondary distant metastatic breast cancer: two sides of the same coin.
    Güth U, Magaton I, Huang DJ, Fisher R, Schötzau A, Vetter M.
    Breast; 2014 Feb 15; 23(1):26-32. PubMed ID: 24215983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.